Myeloma UK and the Structural Genomics Consortium announce open-access collaboration to discover new drug targets for myeloma

Myeloma UK and the Structural Genomics Consortium (SGC) have entered into an open-access research partnership to discover and characterise novel drug targets for myeloma using structural biology… Source link